natgillin/translations-raw huggingface dataset:
are currently being treated with another medicine which may cause liver damage. are taking other medicines containing duloxetine (see ‘Other medicines and YENTREVE’)
e trenutačno liječite nekim drugim lijekom koji može uzrokovati oštećenje jetre uzimate druge lijekove koji sadrže duloksetin (vidjeti ‘Drugi lijekovi i YENTREVE’).
are currently being treated with another medicine which may cause liver damage; are taking other medicines containing duloxetine (see ‘Other medicines and Duloxetine Zentiva’).
ako se trenutačno liječite nekim drugim lijekom koji može izazvati oštećenje jetre ako uzimate druge lijekove koji sadrže duloksetin (pogledajte ‘Drugi lijekovi i Duloxetine Zentiva’)
are diabetic or have high blood pressure, your doctor may ask you, or the child you are caring for to have an eye examination.
vrućica, kašalj ili bilo kakva poteškoća s disanjem, ako bolujete od šećerne bolesti ili imate povišen krvni tlak, liječnik Vas ili dijete o kojem skrbite može uputiti na pregled očiju,
are elderly (≥ 65 years);
te u starijoj životnoj dobi (≥ 65 godina),
are excluded, and the testing of each donation and pools of plasma for signs of virus/infections.
prenijeti infekcije i pregled svake donirane krvi i plazme radi znakova virusa/infekcija.
are going to have planned surgery, if you had recent surgery or if you have poor wound healing after surgery.
idete na ranije dogovorenu operaciju, ako ste nedavno imali operaciju ili ako Vam rana nakon kirurškog zahvata teško cijeli.
are going to receive any vaccination or have recently had a vaccination.
ćete primiti cjepivo ili ste nedavno cijepljeni.
are in the form of the glucuronide in systemic circulation.
Dio M1 u sistemskoj cirkulaciji je u obliku glukuronida.
are lower with antacids due to
niže su s antacidima zbog lokalne
are not feeling any better as vedolizumab may take up to 14 weeks to work in some patients with very active Crohn’s disease.
se ne osjećate bolje budući da u nekih bolesnika s vrlo aktivnom Crohnovom bolesti vedolizumab može početi djelovati tek nakon 14 tjedana
are not likely to be
primjena maraviroka utjecati
are not sensitive to human normal immunoglobulin by initially injecting the product slowly (at an initial rate of 0.01-0.02 ml/kg/min) are carefully monitored for any symptoms throughout the infusion period.
bolesnici nisu osjetljivi na normalni ljudski imunoglobulin, što se ispituje polaganom početnom brzinom injiciranja lijeka (od 0,01 - 0,02 ml/kg/min) bolesnike se potom pažljivo promatra tijekom infuzije kako bi se opazili svi simptomi.
are not sensitive to human normal immunoglobulin, by initially injecting the product slowly (see section 4.2); are carefully monitored for any symptoms throughout the infusion period.
nisu osjetljivi na ljudski normalni imunoglobulin, polaganim injiciranjem lijeka na početku liječenja (vidjeti dio 4.2); budu pažljivo promatrani u svrhu uočavanja eventualnih simptoma tijekom razdoblja primjene infuzije.
are not sensitive to human normal immunoglobulin, by initially injecting the product slowly; are carefully monitored for any symptoms throughout the injection.
provjeravajući osjetljivost bolesnika na ljudski normalni imunoglobulin početnim sporim injiciranjem lijeka pažljivim promatranjem simptoma za vrijeme davanja injekcije.
are obese (overweight); are a smoker.
te pretili (imate povećanu tjelesnu težinu), pušite.
are older than 3 years of age and below 8 years of age and weigh 25 kg or more have a body surface area of 1.17 square metres or above.
u stariji od 3 i mlađi od 8 godina starosti te teže 25 kg ili više imaju površinu tijela 1,17 kvadratnih metara ili više
are older than 65 years or if you have problems with your kidneys.
tariji od 65 godina ili imate tegoba s bubrezima.
are or become dehydrated
te ili postajete dehidrirani
are other treatments for cancer. are used for contraception.
druge terapije za rak. uzimaju se za sprječavanje trudnoće.
are passing more than a certain amount of protein with your urine or if you develop a severe kidney disease (nephrotic syndrome) develop abnormal tube-like connections or passageways inside the body between internal organs and skin or other tissues (fistula)
izmokravate preveliku količinu proteina ili ako se razvije teška bubrežna bolest (nefrotski sindrom) nastanu neuobičajene cjevaste spojnice ili prolazi unutar tijela između unutarnjih organa i kože ili drugih tkiva (fistula)
are planning to become pregnant, discuss this with your doctor before starting to use this medicine. have received an organ transplant, either kidney or liver, interferon treatment may increase the risk of rejection.
ako planirate trudnoću, porazgovarajte o tome s liječnikom prije nego počnete uzimati ovaj lijek, ako ste primili presadak organa, bilo bubrega ili jetre, liječenje interferonom može povećati rizik od odbacivanja.
are pregnant
ako ste trudni
are pregnant or breast-feeding
te trudni ili dojite
are pregnant or think that you may be pregnant
ako ste trudni ili mislite da biste mogli biti trudni
are pregnant or think that you may be pregnant.
trudni ili mislite da biste mogli biti trudni,
are pregnant or think you may be pregnant are breast-feeding
ako ste trudni ili mislite da biste mogli biti trudni ako dojite
are pregnant or think you may be pregnant are breast-feeding
ako ste trudni ili mislite da biste mogli biti trudni ako dojite.
are pregnant or think you may be pregnant are breast-feeding
te trudni ili mislite da biste mogli biti trudni dojite
are pregnant,
ako ste trudni
are pregnant. are breast-feeding.
ako ste trudni ako dojite.
are pregnant;
ako ste trudni
are pregnant;
ako ste trudni;
are pregnant;
te trudni
are pregnant;
te trudni;
are pregnant;
trudni,
are pregnant;
trudni;
are receiving azathioprine in combination with ribavirin and pegylated alpha interferons and, therefore may be at an increased risk of developing severe blood disorders. are infected with both Human Immunodeficiency Virus (HIV-positive) and Hepatitis C Virus (HCV) and are being treated with an anti-HIV medicinal product(s) – [nucleoside reverse transcriptase inhibitor (NRTI), and/or highly active anti-retroviral therapy (HAART)]:
primate azatioprin u kombinaciji s ribavirinom i pegiliranim alfa interferonima jer možete biti izloženi povećnom riziku za razvoj teških poremećaja krvi. imate infekciju i virusom humane imunodeficijencije (HIV-pozitivni) i virusom hepatitisa C (HCV) i liječite se lijekom ili lijekovima protiv HIV-a [nukleozidnim inhibitorom reverzne transkriptaze (NRTI) i/ili vrlo djelotvornom antiretrovirusnom terapijom (HAART)]:
are receiving chemotherapy, radiation treatment or immunosuppression;
primaju kemoterapiju, liječenje radioterapijom ili imunosupresijom;
are recommended (ie 150 mg on alternate days, or three times per
150 mg svaki drugi dan, ili tri puta tjedno).
are regularly using a prescribed opioid medicine (e.g. codeine, fentanyl, hydromorphone, oxycodone);
redovito primjenjujete propisani opioidni lijek (npr. kodein, fentanil, hidromorfon, oksikodon);
are suffering from diarrhoea, or have suffered from diarrhoea whilst (or up to 2 months after) being treated with antibiotics in the past.
ako imate proljev, ili ste dobili proljev u prošlosti za vrijeme uzimanja antibiotika (ili najviše 2 mjeseca nakon toga);
are suffering from diarrhoea, or have suffered from diarrhoea whilst (or up to 2 months after) taking antibiotics in the past.
ako imate proljev, ili ste dobili proljev u prošlosti za vrijeme uzimanja antibiotika (ili najviše 2 mjeseca nakon toga);
Are taking allergy medicines
uzimate lijekove protiv alergije,
are taking any form of organic nitrate or nitric oxide donors such as amyl nitrite.
ako uzimate bilo koji oblik organskih nitrata ili donore dušikova oksida poput amil nitrata.
are taking any of the following medicines used to treat high blood pressure: an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems. aliskiren
ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću aliskiren.
are taking any of the following medicines used to treat high blood pressure: an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems. aliskiren.
ACE inhibitor (primjerice enalapril, lizinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću. aliskiren
are taking certain medicines used to treat migraine known as “triptans,”
ako uzimate određene lijekove za liječenje migrene poznate kao "triptani", primjerice
are taking fluvoxamine which is usually used to treat depression, ciprofloxacin or enoxacin which are used to treat some infections are taking other medicines containing duloxetine (see ‘Other medicines and ARICLAIM’)
uzimate fluvoksamin koji se obično koristi za liječenje depresije, ciprofloksacin ili enoksacin koji se koriste za liječenje nekih infekcija uzimate druge lijekove koji sadrže duloksetin (vidjeti ‘Drugi lijekovi i ARICLAIM’’)
are taking fluvoxamine which is usually used to treat depression, ciprofloxacin or enoxacin which are used to treat some infections are taking other medicines containing duloxetine (see ‘Other medicines and Duloxetine Lilly’)
ako uzimate fluvoksamin, koji se obično koristi za liječenje depresije, ciprofloksacin ili enoksacin, koji se koriste za liječenje nekih infekcija ako uzimate druge lijekove koji sadrže duloksetin (pogledajte ‘Drugi lijekovi i Duloksetin Lilly’)
are taking fluvoxamine which is usually used to treat depression, ciprofloxacin or enoxacin which are used to treat some infections are taking other medicines containing duloxetine (see ‘Other medicines and Duloxetine Mylan’)
ako uzimate fluvoksamin, koji se obično koristi za liječenje depresije, ciprofloksacin ili enoksacin, koji se koriste za liječenje nekih infekcija ako uzimate druge lijekove koji sadrže duloksetin (pogledajte ‘Drugi lijekovi i Duloxetine Mylan’)
are taking medicines called corticosteroids (such as prednisolone or dexamethasone). have cancer.
uzimate lijekove zvane kortikosteroidi (poput prednizolona ili deksametazona). imate rak.
are taking medicines for high blood pressure
uzimate lijekove za visoki krvni tlak
are taking medicines to control your heart rhythm, have a slow heart rate, have problems with your heart or have problems with the levels of calcium, potassium or magnesium in your blood have severe liver or kidney disease.
uzimate lijekove za kontroliranje srčanog ritma, imate usporen srčani ritam, imate probleme sa srcem ili probleme s razinom kalcija, kalija ili magnezija u krvi imate tešku bolest jetre ili bubrega.
are taking medicines which may affect the level of lurasidone in your blood such as:
ako uzimate lijekove koji mogu utjecati na razinu lurasidona u krvi, kao što su:
are taking medicines with a so-called serotonergic effect, such as:
uzimate lijekove s takozvanim serotonergičkim učinkom, kao što su:
are taking or have recently taken any other medicines or vitamins/nutritional supplements, including medicines obtained without a prescription. are infected with both Human Immunodeficiency Virus (HIV-positive) and Hepatitis C Virus (HCV) and are being treated with an anti-HIV medicine(s) – [nucleoside reverse transcriptase inhibitor (NRTI), and/or highly active anti-retroviral therapy (HAART)].
uzimate ili ste nedavno uzeli bilo koje lijekove ili vitamine/dodatke prehrani, uključujući lijekove koje ste nabavili bez recepta. imate infekciju i virusom humane imunodeficijencije (HIV pozitivni) i virusom hepatitisa C (HCV) i uzimate lijek(ove) protiv HIV-a (nukleozidne inhibitore reverzne transkriptaze i/ili vrlo djelotvornu antiretrovirusnu terapiju).
are taking or have recently taken any other medicines, including medicines obtained without a prescription.
uzimate ili ste nedavno uzimali bilo koje druge lijekove, uključujući i one koje ste nabavili bez recepta.
are taking other fluoropyrimidine anti-cancer medicine such as fluorouracil and capecitabine, or have had severe and unexpected reactions to fluoropyrimidines have known genetic deficiency of the enzyme dihydropyrimidine dehydrogenase (DPD)
uzimate drugi fluoropirimidinski lijek protiv raka kao što je fluorouracil i kapecitabin ili ste imali teške i neočekivane reakcije na fluoropirimidine imate poznati genetski nedostatak enzima dihidropirimidin dehidrogenaze (DPD)
are taking other fluoropyrimidine anti-cancer medicine such as fluorouracil and capecitabine, or have had severe and unexpected reactions to fluoropyrimidines have known genetic deficiency of the enzyme dihydropyrimidine dehydrogenase (DPD)
uzimate drugi fluoropirimidinski lijek protiv raka kao što su fluorouracil i kapecitabin ili ste imali teške i neočekivane reakcije na fluoropirimidine imate poznati genetski nedostatak enzima dihidropirimidin dehidrogenaze (DPD)
are taking other medicines that suppress your immune system (that protects you against infection and some diseases)
imate autoimuni hepatitis ili neku drugu bolest imunološkog sustava uzimate druge lijekove koji oslabljuju Vaš imunoški sustav (koji Vas štiti od infekcija i određenih bolesti).
are taking riociguat.
ako uzimate riocigvat.
are taking the contraceptive pill or hormone replacement therapy;
uzimate kontracepcijske tablete ili hormonsku nadomjesnu terapiju,
Are taking the herbal remedy St John’s Wort
uzimate biljni lijek gospinu travu;
are taking treatment for human immunodeficiency virus (HIV) infection, since your doctor may want to monitor you more closely.
ako uzimate liječenje za injkeciju virusom humane imunodeficijencije (HIV), budući da bi Vas liječnik možda htio pažljivije pratiti.
Are the Numbers 1, 2 & 3 how I select my dose of medicine?
Određuju li brojevi 1, 2 i 3 način odabira doze lijeka?
are used for heart problems and complications (such as digoxin), or for thinning the blood (such as warfarin).
uzimaju se u slučaju tegoba i komplikacija sa srcem (kao što je digoksin) ili za razrjeđivanje krvi (kao što je varfarin).
are vomiting, have recently had severe vomiting, or have diarrhoea
ako povraćate, ako ste nedavno jako povraćali ili imate proljev
are vomiting, have recently had severe vomiting, or have diarrhoea.
ako povraćate, ako ste nedavno jako povraćali ili imate proljev.
Are you taking any medicines containing: azathioprine or other immunosuppressive agents (which are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients with high blood cholesterol), rifampicin (antibiotic), antacids or proton pump inhibitors (used for acid problem in your stomach such as indigestion), phosphate binders (used in patients with chronic kidney failure to reduce the absorption of phosphate) or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
Uzimate li bilo koji lijek koji sadrži azatioprin ili druge imunosupresivne lijekove (koji se ponekad daju bolesnicima nakon presađivanja), kolestiramin (koristi se za liječenje bolesnika s visokim kolesterolom u krvi), rifampicin (antibiotik), antacide, lijekove koji vežu fosfate (primjenjuju se kod bolesnika s kroničnim bubrežnim zatajenjem kako bi se smanjila apsorpcija fosfata) ili bilo koje druge lijekove (uključujući one koji se mogu kupiti bez recepta) koje Vam liječnik nije propisao?
Are you taking any medicines containing: azathioprine or other immunosuppressive agents (which are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients with high blood cholesterol), rifampicin (antibiotic), antacids or proton pump inhibitors (used for acid problem in your stomach such as indigestion), phosphate binders (used in patients with chronic kidney failure to reduce the absorption of phosphate), or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
Uzimate li bilo koji lijek koji sadrži azatioprin ili druge imunosupresivne lijekove (koji se ponekad daju bolesnicima nakon presađivanja), kolestiramin (koristi se za liječenje bolesnika s visokim kolesterolom u krvi), rifampicin (antibiotik), antacide, lijekove koji vežu fosfate (primjenjuju se kod bolesnika s kroničnim bubrežnim zatajenjem kako bi se smanjila apsorpcija fosfata) ili bilo koje druge lijekove (uključujući one koji se mogu kupiti bez recepta) koje Vam Vaš liječnik nije propisao?
are  8 years of age and weigh 43.8 kg or more
u ≥ 8 godina starosti i teže 43,8 kg ili više
are  8 years of age and weigh 43.8 kg or more or
 8 godina statosti i 43,8 kg il više ili
are, or become dehydrated
te dehidrirali
Area (m2)
površina (m2)
Area under the curve (AUC0-72h)
Površina ispodkrivulje (AUC0-72h)
Area under the curve: 587.88 ± 1.63 (% x h)
Površina ispod krivulje: 587,88 ± 1,63 (% x h)
Area under the plasma concentration curve (AUC) of ertapenem in adults increases nearly dose- proportionally over the 0.5 to 2 g dose range.
Površina ispod krivulje (AUC) koncentracije ertapenema u plazmi u odraslih povećava se gotovo proporcionalno dozi u rasponu doza od 0,5 do 2 g.
area. d Patients in whom the first treatment course did lead to complete clearance and who had a recurrence in the treatment area at either week 26 or 44.
liječenom području. d Bolesnici kod kojih je prvi ciklus liječenja doveo do potpunog nestanka i koji su imali povrat u liječenom području nakon 26 ili 44 tjedana.
Areas of skin without any colour (vitiligo), rash, inflamed skin (dermatitis)
Područja kože bez ikakve boje (vitiligo), osip, upaljena koža (dermatitis)
Areas with a good amount of fat below the skin (thigh, arm) are the most suitable areas to inject.
Za primjenu injekcije najpogodnija su područja s dosta masnog tkiva ispod kože (bedra, ruka).
Areflexia1, headache
Arefleksija1, glavobolja
aResponders were defined as those patients who 1) experienced a ≥ 30% drop in VASPI score compared to baseline; 2) had stable or decreased concomitant opioid analgesics; and 3) had opiate type unchanged from preinfusion if receiving opiates.
aBolesnici s odgovorom definirani su kao bolesnici koji su: 1) imali pad ≥ 30% u rezultatu VASPI u usporedbi s onim prije liječenja; 2) primali su stabilnu ili smanjenu dozu opioidnih analgetika; i
aResponders were defined as those patients who 1) experienced a ≥ 30% drop in VASPI score compared to baseline; 2) had stable or decreased concomitant opioid analgesics; and 3) had opiate type unchanged from preinfusion if receiving opiates. b164 patients provided VASPI scores for ziconotide at the end of titration.
aBolesnici s odgovorom definirani su kao bolesnici koji su: 1) imali pad ≥ 30% u rezultatu VASPI u usporedbi s onim prije liječenja; 2) primali su stabilnu ili smanjenu dozu opioidnih analgetika; i
aResponders were defined as those who experienced a ≥ 30% drop in VASPI score compared to baseline.
aBolesnici s odgovorom bili su definirani kao bolesnici koji su imali pad ≥ 30% u rezultatu VASPI u usporedbi s onim prije liječenja.
aResponders were defined as those who experienced a ≥ 30% drop in VASPI score compared to baseline.
aBolesnici s odgovorom definirani su kao bolesnici koji su imali pad ≥ 30% u rezultatu VASPI u usporedbi s onim prije liječenja.
Arginine
Arginin.
Arginine hydrochloride
argininklorid
Arginine hydrochloride.
Argininklorid.
Arginine, sodium acetate (E262), sodium chloride, polysorbate 80 (E433), edetate disodium (E386), hydrochloric acid (E507), water for injections.
Arginin, natrijev acetat (E262), natrijev klorid, polisorbat 80 (E433), dinatrijev edetat (E386) kloridna kiselina (E507), voda za injekcije
ARICLAIM 30 mg hard gastro-resistant capsules
ARICLAIM 30 mg tvrde želučanootporne kapsule
ARICLAIM 30 mg hard gastro-resistant capsules ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)
ARICLAIM 30 mg tvrde želučanootporne kapsule ARICLAIM 60 mg tvrde želučanootporne kapsule duloksetin (u obliku duloksetinklorida)
ARICLAIM 30 mg hard gastro-resistant capsules Duloxetine
ARICLAIM 30 mg tvrde želučanootporne kapsule duloksetin
ARICLAIM 30 mg is available in packs of 7, 28 and 98 capsules.
ARICLAIM 30 mg dostupan je u pakiranjima koja sadrže 7, 28 i 98 kapsula.
ARICLAIM 60 mg hard gastro-resistant capsules
ARICLAIM 60 mg tvrde želučanootporne kapsule
ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine
ARICLAIM 60 mg tvrde želučanootporne kapsule duloksetin
ARICLAIM 60 mg is available in packs of 28 and 98 capsules.
ARICLAIM 60 mg dostupan je u pakiranjima koja sadrže 28 i 98 kapsula.
ARICLAIM contains the active substance duloxetine.
ARICLAIM sadrži djelatnu tvar duloksetin.
ARICLAIM is a hard gastro-resistant capsule.
ARICLAIM je tvrda želučanootporna kapsula.
Ariclaim may cause effects that you may not be aware of, such as increases in liver enzymes or blood levels of potassium, creatine phosphokinase, sugar, or cholesterol
ARICLAIM može uzrokovati učinke kojih možda i niste svjesni, poput povišenja jetrenih enzima ili povišenih razina kalija, kreatin fosfokinaze, šećera ili kolesterola u krvi
ARICLAIM must not be used in patients with liver disease resulting in hepatic impairment (see sections 4.3 and 5.2).
ARICLAIM se ne smije primjenjivati u bolesnika s bolešću jetre čija je posljedica oštećenje jetrene funkcije (vidjeti dijelove 4.3 i 5.2).
ARICLAIM should be used with caution in patients with a history of mania or a diagnosis of bipolar disorder, and/or seizures.
ARICLAIM se mora s oprezom primjenjivati kod bolesnika s manijom u anamnezi ili s dijagnozom bipolarnog poremećaja i/ili napadaja.
ARICLAIM should not be used in the treatment of children and adolescents under the age of 18 years.
ARICLAIM se ne smije primjenjivati u liječenju djece i adolescenata mlađih od 18 godina.
Aripiprazole 10 mg (n = 27)
Aripiprazole Mylan Pharma 10 mg
Aripiprazole 10 mg (n = 37)
Aripiprazole Mylan Pharma 10 mg
Aripiprazole 10 mg (n = 44)
Aripiprazole Mylan Pharma 10 mg
Aripiprazole 10 mg (n = 48)
Aripiprazole Mylan Pharma 10 mg
Aripiprazole 10 mg (n=27)
Aripiprazol 10 mg (n = 27)
Aripiprazole 10 mg (n=37)
Aripiprazol 10 mg (n = 37)
Aripiprazole 10 mg (n=44)
Aripiprazol 10 mg (n = 44)
Aripiprazole 10 mg (n=48)
Aripiprazol 10 mg (n = 48)
Aripiprazole 30 mg (n = 25)
Aripiprazole Mylan Pharma 30 mg
Aripiprazole 30 mg (n = 30)
Aripiprazole Mylan Pharma 30 mg
Aripiprazole 30 mg (n = 48)
Aripiprazole Mylan Pharma 30 mg
Aripiprazole 30 mg (n = 51)
Aripiprazole Mylan Pharma 30 mg
Aripiprazole 30 mg (n=25)
Aripiprazol 30 mg (n = 25)
Aripiprazole 30 mg (n=30)
Aripiprazol 30 mg (n = 30)
Aripiprazole 30 mg (n=48)
Aripiprazol 30 mg (n = 48)
Aripiprazole 30 mg (n=51)
Aripiprazol 30 mg (n = 51)
Aripiprazole Accord 10 mg
Aripiprazol Accord 10 mg
Aripiprazole Accord 10 mg (n = 27)
Aripiprazol Accord 10 mg (n = 27)
Aripiprazole Accord 10 mg (n = 37)
Aripiprazol Accord 10 mg (n = 37)
Aripiprazole Accord 10 mg (n = 44)
Aripiprazol Accord 10 mg (n = 44)
Aripiprazole Accord 10 mg (n = 48)
Aripiprazol Accord 10 mg (n = 48)
Aripiprazole Accord 10 mg tablets aripiprazole
Aripiprazol Accord 10 mg tablete aripiprazol
Aripiprazole Accord 15 mg
Aripiprazol Accord 15 mg
Aripiprazole Accord 15 mg tablets aripiprazole
Aripiprazol Accord 15 mg tablete aripiprazol
Aripiprazole Accord 30 mg
Aripiprazol Accord 30 mg
Aripiprazole Accord 30 mg (n = 25)
Aripiprazol Accord 30 mg (n = 25)
Aripiprazole Accord 30 mg (n = 30)
Aripiprazol Accord 30 mg (n = 30)
Aripiprazole Accord 30 mg (n = 48)
Aripiprazol Accord 30 mg (n = 48)
Aripiprazole Accord 30 mg (n = 51)
Aripiprazol Accord 30 mg (n = 51)
Aripiprazole Accord 30 mg tablets are pink colored, approximately 9.1 mm in diameter, round shaped, bevelled edge, biconvex, uncoated tablets, debossed with “A30” on one side and another side is plain.
Aripiprazol Accord 30 mg tablete su ružičaste, okrugle, bikonveksne neobložene tablete ukošene na rubovima, promjera oko 9,1 mm s utisnutom oznakom „A30“ na jednoj strani i bez oznake na drugoj strani.
Aripiprazole Accord 30 mg tablets aripiprazole
Aripiprazol Accord 30 mg tablete aripiprazol
Aripiprazole Accord 5 mg
Aripiprazol Accord 5 mg